Bethesda, April 06, 2016 -- India Globalization Capital, Inc. (IGC) announces today that it has acquired 51% of M10-Plantation, a company located in Malaysia with expertise in vertical farming, for a consideration of 1,000,000 shares of unregistered IGC common stock comprising a purchase price of $520,000. The acquisition closed, subject to customary closing conditions, on March 31, 2016. The Company will have about 24,289,220 shares outstanding after giving effect to this acquisition.
Mr. Ram Mukunda, CEO of IGC commented, “This acquisition does three things for us: 1) it gives us access to advanced technology for growing, extraction, storage, and packaging that we can apply in the U.S.; 2) it generates cash flow in the short term; 3) it allows us to create a low cost R&D center for training individuals in advanced growing, green house, and extraction technologies. Our recently acquired management team at Cabaran Ultima will help manage this acquisition.”
About IGC
In the United States, we develop phytocannabinoid-based therapies and build state-of-the art farming facilities that we can eventually use to grow and extract pharmaceutical grade phytocannabinoids. IGC has several patent filings for the indications of Pain, Medical Refractory Epilepsy and Cachexia using cannabinoids. Internationally, IGC engages in leasing, trading and managing infrastructure projects. We are based in Bethesda, Maryland.
Our website: www.igcinc.us. Twitter @IGCIR
Forward-looking Statements:
Some of the statements contained in this press release that are not historical facts constitute forward- looking statements under the federal securities laws. Forward-looking statements can be identified by the use of the words "may," "will," "should," "could," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "intends," "potential," "proposed," or the negative of those terms. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond IGC's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, our acquisition and diversification strategy, our competitive environment, and governmental, regulatory, political, economic, legal and social conditions. Except as required by federal securities laws, IGC undertakes no obligation to publicly update any forward- looking statements, whether as a result of new information, future events, or otherwise. Other factors and risks that could cause or contribute to actual results differing materially from such forward- looking statements have been discussed in greater detail in IGC's Form 10- K for fiscal year ended March 31, 2015, and in subsequent reports filed with the U.S. SEC.
Claudia Grimaldi Phone: 301-983-0998


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 



